Technology and products
Article Abstract:
Denver, CO-based Ischemia Technologies filed a 510(k) pre-market notification with the FDA for clearance to market its Albumin Cobalt Binding (ACB) test. The test lets emergency personal know if a patient can be ruled out for heart attack.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Genset/Sonofi: CNS drug discovery
Article Abstract:
Paris, France-based Genset has signed an agreement with New York, NY-based Sanofi-Synthelabo to initiate a pharmacogenomics collaboration focused on lead selection and optimization for an undisclosed CNS disease.
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Medicine and applications
Article Abstract:
The introduction of clot-busting drugs has dramatically the death rates from stroke and acute myocardial infarction (AMI).
Publication Name: Genesis Report-Dx
Subject: Health care industry
ISSN: 1061-2289
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Medicine and applications: biochips. Medicine and applications. PE Biosystems: automated system for genotyping of mutations in HIV
- Abstracts: Identifying new patient prospects: efficacy of usage segmentation. Complaint intensity and health care services: a framework to establish priorities for quality improvements can be used to improve patient satisfaction
- Abstracts: Physician opportunity costs in physician practice cost functions. A problem with consumer surplus measures of the cost of practice variations
- Abstracts: CPRTraining. Theory and reality. The health care 100
- Abstracts: The pills that ate your profits. Look before you launch. Medicaid: states serve up a real turkey